Astex Therapeutics, the leading fragment-based drug discovery company, today announced that it has successfully achieved two scientific milestones in its drug discovery collaboration with Janssen Pharmaceutica NV.
126233
Astex achieves milestones in drug discovery collaboration
105963
Lancaster Laboratories collaborates with BioAzure
79889
Merck buys drug rival Schering-Plough
110579
Scientists harness new drug discovery tool to treat diabetes
86160
Tekmira Pharmaceuticals receives $2.4 million grant from National Institutes of Health
78447
Abbott and Reata Pharmaceuticals announce agreement to develop
61307
Advantest's terahertz spectroscopic/imaging system TAS7500 adopted by Astellas Pharma Inc.
173138
Milestone Scientific acquires additional patent rights for painless injections
88710
Nanoviricides completes a number of financing activities
153612
Antisoma starts phase IIb trial of AS1411
128394
Two new drugs can slash stroke risk
66355
Pain Therapeutics receives milestone payment from King Pharmaceuticals
172362
Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts
25549
Scientists working on a new cancer drug
88480
Mayo Clinic partnership to advance personalized medicine
42103
Dynogen goes public via reverse merger
7541
Xyratex expands product portfolio